Exclusive

Publication

Byline

Eris Lifesciences buys anti-diabetes novel drug Zomelis in India for $13 million

New Delhi, Dec. 3 -- Eris Lifesciences on Tuesday announced the acquisition of the trademark for anti-diabetes novel drug Zomelis for $13 million, the company said in a release. The acquisition of the... Read More


Bharat Biotech launches new variant of rotavirus vaccine, Rotavac 5D

New Delhi, Dec. 3 -- Bharat Biotech International on Tuesday launched a new variant of its rotavirus vaccine, Rotavac 5D, a smaller dosage form of its earlier oral immunisation shot that can be stored... Read More


Biocon, partner Mylan launch oncology biosimilar trastuzumab in US

New Delhi, Dec. 2 -- Biocon Ltd and its partner Mylan on Monday announced the much-awaited launch of their biosimilar to oncology drug trastuzumab in the US under the brand Ogivri. A biosimilar to F.... Read More


Syngene appoints former Vodafone executive Sibaji Biswas as CFO

New Delhi, Dec. 2 -- Biocon Ltd's contract manufacturing subsidiary Syngene International Ltd has appointed Sibaji Biswas as chief financial officer, effective 18 December. Biswas was the CFO and boa... Read More


Niti Aayog calls healthcare system a "sinking ship," urges private participation in Ayushman Bharat

New Delhi, Nov. 28 -- India's top think tank said Thursday that the country's healthcare system resembled a "sinking ship" and desperately needs more private participation in smaller towns to run the ... Read More


NITI Aayog advisor calls for govt hospitals in smaller cities to be managed by private players

New Delhi, Nov. 28 -- In an admission of the massive task at hand to improve the healthcare sector, NITI Aayog advisor Alok Kumar called India's current system of healthcare a "sinking ship" and urged... Read More


Govt plans to invest 550 cr in HLL Biotech's vaccine facility

New Delhi, Nov. 27 -- India's largest integrated vaccine complex outside Chennai, which was struggling to start production, is likely to get a new lease of life through a fund infusion from the centra... Read More


Biocon gets US FDA approval for new facility in Bengaluru

New Delhi, Nov. 27 -- The US Food and Drug Administration (FDA) has approved Biocon Ltd's new facility at Bengaluru for the manufacturing of pegfilgrastim biosimilar Fulphila, the company said in a re... Read More


Indian regulator flags products of three pharma PSUs for failing quality test

New Delhi, Nov. 27 -- The Central Drugs Standard Control Organization (CDSCO), in its latest drug alert, pulled up five batches of medicines of three government-run pharmaceutical companies for failin... Read More


Govt plans to invest Rs.550 crore in HLL Biotech's vaccine facility

New Delhi, Nov. 26 -- India's largest upcoming integrated vaccine complex, which was struggling to start production, would likely get a new lease of life through a fund infusion from the central gover... Read More